|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S5
|
$11,164,583
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S6
|
$75,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA030199-30S1
|
$82,436
|
VUORI, KRISTIINA
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
Cancer Center Support Grant
|
5P30CA030199-30
|
$3,886,604
|
VUORI, KRISTIINA
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
Cancer Center Support Grant
|
3P30CA008748-46S1
|
$249,999
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer Center Support Grant
|
3P30CA008748-46S2
|
$50,000
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer Center Support Grant
|
3P30CA008748-46S3
|
$75,000
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer Center Support Grant
|
5P30CA008748-46
|
$13,185,550
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer Center Support Grant
|
3P30CA091842-10S1
|
$49,953
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-10S2
|
$75,000
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-10
|
$4,380,520
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Carbohydrate-Dependent Adhesion in Normal and Tumor Cells
|
5P01CA071932-14
|
$1,383,405
|
FUKUDA, MINORU
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
Clinical and Genetic Studies of Neurofibromatosis Type 1
|
ZIA CP010144-10567
|
$193,299
|
Stewart, Douglas
|
DCEG (NCI)
|
|
Comprehensive Cancer Center Core Support Grant
|
2P30CA013148-39
|
$5,476,332
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Comprehensive Cancer Center Core Support Grant
|
3P30CA013148-39S1
|
$250,000
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Comprehensive Cancer Center Core Support Grant
|
3P30CA013148-39S2
|
$75,001
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Comprehensive Cancer Center Program at Fox Chase
|
2P30CA006927-48
|
$4,038,908
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-48S1
|
$50,859
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-48S2
|
$74,930
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-48S3
|
$140,001
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-48S4
|
$300,000
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Cutaneous Lesions in Neurofibromatosis Type I and Other Pre-cancerous Syndromes
|
ZIA BC 010734
|
$48,425
|
Hornyak, Thomas
|
CCR (NCI)
|
|
Development of Mouse Astrocytoma Model for Preclinical Testing
|
ZIA BC 010541
|
$92,121
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Development of Therapies for Neurofibromatosis Type 1 Related Tumors and other Ge
|
ZIA BC 010801
|
$976,696
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Elucidating the Function of the NF1 tumor suppressor and its effector pathways in
|
5R01CA111754-07
|
$284,401
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Elucidating the role of the mTOR pathway in NF1-related tumorigenesis
|
5R01CA129814-05
|
$318,505
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$904,190
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
ZIA BC 010539
|
$644,844
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-13S1
|
$108,772
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-13S2
|
$49,994
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-13
|
$1,145,097
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Mechanism of Merlin-mediated contact inhibition and tumor suppression.
|
5R01CA152975-02
|
$550,538
|
GIANCOTTI, FILIPPO
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Molecular Function of the Nf2 Tumor Suppressor, Merlin
|
5R01CA113733-07
|
$331,162
|
MCCLATCHEY, ANDREA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma
|
ZIA BC 010540
|
$184,241
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Multi-Modal Lysosomotropic Death Therapy for Malignant Peripheral Nerve Sheath Tu
|
5R01CA134773-03
|
$235,894
|
ROTH, KEVIN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
|
5R01CA074177-14
|
$314,738
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath Tumors
|
5R01CA122804-04
|
$291,849
|
CARROLL, STEVEN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
p21-Activated Kinases as New Therapeutic Targets in Neurofibromatosis Type 1
|
5R01CA142928-02
|
$395,129
|
CHERNOFF, JONATHAN
|
INSTITUTE FOR CANCER RESEARCH
|
|
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach
|
ZIA BC 011240
|
$306,212
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 010764
|
$2,572,000
|
Wayne, Alan
|
CCR (NCI)
|
|
REGULATION AND ROLE OF MTOR IN NEUROFIBROMIN GROWTH CONTROL
|
5R01CA127008-04
|
$404,112
|
Weber, Jason
|
WASHINGTON UNIVERSITY
|
|
Role of AML1-ETO in Acute Leukemia
|
5R01CA064140-18
|
$307,553
|
HIEBERT, SCOTT
|
VANDERBILT UNIVERSITY
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$388,254
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Schwann Cells in Neurofibromatosis Type 2 (NF2)
|
5R01CA118032-05
|
$276,450
|
RATNER, NANCY
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
|
STROMAL CONTRIBUTIONS TO NF1 GLIOMA FORMATION AND GROWTH
|
5R01CA136573-03
|
$305,938
|
RUBIN, JOSHUA
|
WASHINGTON UNIVERSITY
|
|
Targeting Stoma-Tumor Co-Dependency for Glioma Therapy
|
3U01CA141549-03S1
|
$82,601
|
Gutmann, David
|
WASHINGTON UNIVERSITY
|
|
Targeting Stoma-Tumor Co-Dependency for Glioma Therapy
|
5U01CA141549-03
|
$842,595
|
Gutmann, David
|
WASHINGTON UNIVERSITY
|
|
TAS::75 0849::TAS INCREMENTAL FUNDING
|
N01CO800001-038
|
$221,493,424
|
HEIMBROOK, DAVID
|
SAIC-FREDERICK, INC.
|
|
The Role of p21-Activated Kinases in Malignant Mesothelioma
|
1R01CA148805-01A1
|
$366,583
|
CHERNOFF, JONATHAN
|
INSTITUTE FOR CANCER RESEARCH
|
|
Translational Investigation of KRas & NF1 in Myeloid Leukemia
|
5R37CA072614-15
|
$300,946
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|